• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

GenMark Diagnostics Inc.

Roche to acquire GenMark Diagnostics for $1.8B

March 16, 2021 By Sean Whooley

Roche (SWX: RO, ROG) announced that it entered into an agreement to acquire GenMark Diagnostics (NSDQ:GNMK) for $1.8 billion. Basel, Switzerland-based Roche is set to purchase GenMark at $24.05 per share in an all-cash transaction, totaling approximately $1.8 billion on a fully diluted basis. That represents a premium of approximately 43% to GenMark’s unaffected closing […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions, Wall Street Beat Tagged With: GenMark Diagnostics Inc., Roche

Medtronic regulatory chief Susan Alpert to step down

April 8, 2011 By MassDevice staff Leave a Comment

Susan Alpert

Medtronic Inc.’s (NYSE:MDT) chief regulatory affairs officer Susan Alpert will join her boss, William Hawkins, on Retirement Row this year, according to company officials.

Alpert, who has held the senior vice president and chief regulatory officer positions at Medtronic since 2005, had a similar role at C.R. Bard (NYSE:BCR) before joining MDT and is also a former director of the FDA’s Office of Device Evaluation .

Filed Under: News Well Tagged With: Capella Inc., CareFusion Corp., GenMark Diagnostics Inc., HemaCare Corp., OraSure Technologies Inc., Personnel Moves

FDA approves Boston Scientific’s pain management implant “anchor” | Regulatory roundup

March 24, 2011 By MassDevice staff Leave a Comment

Clearances roundup

The FDA granted Boston Scientific Corp. (NYSE:BSX) approval for its anchoring device for the company’s spinal cord stimulator (SCS) implant system.

The Natick, Mass.-based medical device giant designed its new Clik Anchor with locking system to increase the speed with which surgeons place the Precision Plus SCS system’s leads — the wires through which pain-masking electrical pulses are delivered to the spine for chronic pain management.

Filed Under: 510(k), News Well, Pre-Market Approval (PMA) Tagged With: Baxano Surgical, Boston Scientific, Cardiovascular Systems Inc., Fresenius, Fujifilm, GenMark Diagnostics Inc., Intralytix Inc., LensAR Inc., Quest Diagnostics Inc., Small Bone Innovations Inc.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS